Mark E. Baldwin - 24 Feb 2022 Form 4 Insider Report for KBR, INC. (KBR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 Feb 2022, 18:07:07 UTC
Prior SEC filing
11 Aug 2021
Next SEC filing
05 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Adam M. Kramer, Attorney-in-Fact

Key filing fact

Mark E. Baldwin filed Form 4 for KBR, INC. (KBR) on 28 Feb 2022.

Key facts

  • This page summarizes Mark E. Baldwin's Form 4 filing for KBR, INC. (KBR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 28 Feb 2022, 18:07.

Change

  • Previous filing in this sequence was filed on 11 Aug 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KBR transaction

Common Stock

Award

Transaction value
$0
Shares
+3,538
Change %
+6.4%
Price
$0.000000
Shares after
58,700
Date
24 Feb 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Restricted stock units will convert to common stock on a 1-to-1 ratio. 100% of the restricted stock units will vest 6 months after the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .